Dr. Scott K. Thompson, who practices in the Salt Lake City area, is pleased to be in the one of the first among a select group in Utah to incorporate Juvederm Voluma XC into his practice and has noted impressive results of mid-face volume loss in his patients.
Allergan announced that Juvederm Voluma XC was approved for use as a temporary treatment for volume loss in the cheeks associated with aging in October of this year.
"I'm excited to be offering the first FDA-approved hyaluronic acid specifically for the mid-face to patients with age-related and genetic volume loss. Voluma is an excellent addition to the line-up of non-surgical options from Allergan (others include Botox, Juvederm Ultra & Ultra Plus XC) and only expands my options for facial rejuvenation and correction. Administration is safe and the results are instant, natural-looking and long-lasting. Current studies show this revolutionary product lasts up to 2 years. This is significantly longer than any other hyaluronic acid on the market today," said Dr. Thompson.
